Carter Percy H.

Avg. Two Year Performance

No purchase track record

No sale track record

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	--	--	--	--	--
Purchase Success Rate	--	--	--	--	--
Average Sale Return	0%	0%	0%	0%	0%
Sale Success Rate	0 of 1	0 of 1	0 of 1	0 of 1	0 of 1

Blueprint Medicines Corp

Drugs » Biotechnology

Chief Scientific Officer:

Holdings: 48.33K shares

Sentiment

Insider Trading Sentiment: Accumulate

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

($207.32K) Net Amount

Buy:	0	--
Sell:	($207.32K)	$90.69